Virtual drug development

Nick Meyers, VP of Product Development at Boyds, spoke at a recent MarketsAndMarkets event on pragmatic drug development solutions for virtual and semi-virtual sponsors.

In his talk, Nick discussed the pros and cons of taking this virtual drug development route to developing medicines for patient benefit. He also discussed how Boyds can help virtual companies to augment the management team, supporting them all the way through the R&D continuum with Boyds’ in-house capabilities and also via the extensive network helping to find the right partners for the project.

To listen to the talk, click on the link below.

For more information on product development and program management at Boyds, click here.